D

Zoetis Inc. ZTS

$85.57 $2.092.50% NYSE
Recommendation
Dividend Power Score
Day's Range
$82.15$86.58
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
My Lists My Alerts
Access our Premium Ratings
Get Access

ZTS Rating

Reward
Risk

ZTS Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

ZTS Company Overview

Zoetis Inc. is a global animal health company focused on the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests, and precision animal health technologies for livestock and companion animals. The company operates within the broader animal health and veterinary pharmaceuticals industry and serves veterinarians, livestock producers, pet owners, and animal health distributors. Revenue is primarily generated through the sale of animal medicines and vaccines across therapeutic categories including anti-infectives, parasiticides, dermatology, pain management, reproductive products, and diagnostic solutions.

Zoetis traces its origins to Pfizer’s animal health division, which operated for decades before being spun off through an initial public offering in 2013. Since becoming an independent public company, Zoetis has expanded through internal research and targeted acquisitions, strengthening its position in companion animal therapeutics and diagnostics. The company is widely recognized for its scale, broad product portfolio, established veterinary relationships, and diversified exposure across species and geographies. Its strategic positioning is supported by extensive research and development capabilities, global manufacturing infrastructure, and a strong portfolio of established brands in both livestock and pet care markets.

Data compiled by narrative technology. May contain errors.
Sector

ZTS Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

ZTS Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

ZTS Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

ZTS Price History

Loading...
52-Week Range26% of range
Current
$85.57
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

ZTS Valuation

Market Cap
Market Cap Rank
#934
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

ZTS Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

ZTS Corporate Info

Phone Number
973 822 7000
Address
10 Sylvan Way
Parsippany, NJ 07054
Country
Year Founded

ZTS Filings

Filing Date
Thursday, November 5, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Feb 8 and 12 (est)

ZTS Headlines

11/6/2026 - Nasdaq News: Markets
11/6/2026 - Seeking Alpha - Long Ideas
11/6/2026 - Seeking Alpha: Transcripts